Skip to content
Zero malaria deaths are possible—but only if we harness the full power of innovation, partnership, and evidence-based action 29th January 2025

Zero malaria deaths are possible—but only if we harness the full power of innovation, partnership, and evidence-based action.

IVCC CEO Justin McBeath, and IVCC Trustee Keziah Malm, in her role as Program Manager for Ghana’s National Malaria Elimination Program, join Medicines for Malaria Venture and PATH‘s Center for Vaccine Innovation and Access in this compelling opinion piece on achieving zero malaria deaths.

New insecticides are critical for combating resistance in mosquito populations and ensuring the continued effectiveness of widely used interventions such as insecticide-treated bed nets and indoor residual spraying. Vaccines RTS,S and R21 represent a breakthrough in reducing malaria morbidity and mortality, offering protection for children in areas with high and moderate transmission of Plasmodium falciparum, the deadliest form of the malaria parasite. Preventive interventions, such as seasonal malaria chemoprevention and intermittent preventive treatment in pregnancy, among others, protect the two populations most at risk: children and pregnant women.

While each of these tools has significant benefits on its own, their combined use creates a multilayered defense against malaria that is far more powerful than any single intervention. All three are needed to prevent malaria and reduce deaths in different populations and contexts.

Read their insights on how collaboration can transform global health, published in Devex, by following this link: https://ow.ly/KkZ350UBHzE

IVCC & partners at ASTMH 2024 12th November 2024

IVCC will participate at the 2024 Annual Meeting of the American Society of Tropical Medicine (ASTMH) in New Orelans, USA, taking place between 13th and 17th November.

Visit our booth (#516) to find out our latest news and details about our product development pipeline.

Along with our partners, we look forward to contributing insights and progress on expanding the vector control toolbox and the importance of combining tools to achieve malaria elimination.

IVCC CEO, Justin McBeath will participate in the MMV and TDR sponsored scientific symposium on Friday, 15 November from 7:00–8:45 AM in Room 395/396 of the New Orleans Convention Center. It is held in conjunction with the 2024 ASTMH Annual Meeting. ‘Malaria prevention: A trilogy of tools to accelerate to zero deaths‘ will explore how new insecticides, expanded chemoprevention and the first generation of vaccines offer a golden opportunity to bolster the fight against malaria.

Co-chairs: John Reeder, Special Programme for Research and Training in Tropical Diseases, Switzerland and George Jagoe, MMV, Switzerland.

Moderator: Daniel Ngamije Madandi, WHO Global Malaria Programme, Switzerland

IVCC is hosting a sponsored symposium to present the ‘Results from Large-Scale Trials of the Sarabi Attractive Targeted Sugar Bait to Reduce Malaria Burden in Kenya, Mali and Zambia’. It takes place on Friday, 15 November from 7:00 to 8:45 in Room 343/344 (third floor) of the New Orleans Convention Center. The sponsored symposium, held in conjunction with the ASTMH annual meeting and organised in partnership with PATH, will include insights from ATSB project partners* on the entomological and epidemiological impact evaluation of the ATSB® (Attractive Targeted Sugar Baits). Participants include:

Angela Harris, Innovative Vector Control Consortium (IVCC), UK and Busiku Hamainza, of the Zambia Health Ministry will co-chair the session. Speakers include:

For more on the ATSB project, you can also attend presentations and posters outside of the sponsored symposium. A selection are highlighted below. Full details of all ATSB-related presentations visit the scientific program.

On Thursday November 14, 12:00 – 1:45 Convention Center – Hall I-1 [1st Floor]:

On Friday November 15, 11:00 – 11:15, Convention Center – Room 393/394 [3rd floor]:

On Friday November 15, 12:00 – 12:45, Convention Center – Hall I-1 [1st Floor]:

On Saturday November 16, 11:00 – 12:45, Convention Center – Hall I-1 [1st Floor]:

On Saturday November 16, 6:00 – 6:45, Convention Center – Room 353 [3rd Floor]:

IVCC is also co-hosting an invitation-only workshop with Innovation to Impact (I2I) on Wednesday, 13th November, from 15:30 to 19:00. Co-hosted by Rosemary Lees (I2I) and Jason Richardson (IVCC), this workshop will address whether our current methods for evaluating Spatial Repellents (SR)—now under review by the Vector Control Advisory Group (VCAG)—are appropriate and sufficiently validated to produce robust evidence. In preparation, we invite readers to share their insights on the current understanding of SR efficacy and optimal testing methods via a pre-meeting poll (link here). Although attendance is by invitation, the organizers are committed to sharing the workshop’s outcomes with interested stakeholders.

 

* ATSB Project partners are: Westham Co, IVCC, PATH, Liverpool School of Tropical Medicine, University of Science, Technique and Technology of Bamako.

 

Please visit the ASTMH event website for more information.

Sign up to receive the IVCC Newsletter